Allogeneic Micronized Amniotic Membrane Product for the Treatment of Hidradenitis Suppurativa

NCT04541550 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study didn't proceed to FDA submission

Conditions

Hidradenitis Suppurativa

Interventions

DRUG: AMP-001 Low Dose
DRUG: AMP-001 Medium Dose
DRUG: AMP-001 High Dose

Sponsor

IntegoGen, LLC